Brief: Active Biotech Enters Into Clinical Trial Collaboration Agreement

Active Biotech AB publ

31/07/2023 07:54

July 31 (Reuters) - Active Biotech AB publ  ACTI.ST :
    * ACTIVE BIOTECH ENTERS INTO CLINICAL TRIAL COLLABORATION
AGREEMENT FOR A CLINICAL STUDY WITH TASQUINIMOD IN MYELOFIBROSIS
    * PLANNED STUDY WILL INVESTIGATE TASQUINIMOD GIVEN AS
MONOTHERAPY
TO PATIENTS WITH MYELOFIBROSIS

Source text for Eikon:  ID:nMFN5mJtBl 
Further company coverage:  ACTI.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;;))